Trial Profile
Comparison of Glycaemic Fluctuation and Oxidative Stress Between Two Short-term Therapies for Type 2 Diabetes
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Insulin glargine (Primary) ; Gliclazide; Insulin lispro; Metformin
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Acronyms COGFOST
- 24 Aug 2015 New trial record